GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GSK PLC (BUE:GSK) » Definitions » Shiller PE Ratio

GSK (BUE:GSK) Shiller PE Ratio : 10.67 (As of Jul. 25, 2025)


View and export this data going back to . Start your Free Trial

What is GSK Shiller PE Ratio?

As of today (2025-07-25), GSK's current share price is ARS12075.00. GSK's E10 for the quarter that ended in Mar. 2025 was ARS1,131.50. GSK's Shiller PE Ratio for today is 10.67.

The historical rank and industry rank for GSK's Shiller PE Ratio or its related term are showing as below:

BUE:GSK' s Shiller PE Ratio Range Over the Past 10 Years
Min: 8.38   Med: 12.2   Max: 17.38
Current: 10.68

During the past years, GSK's highest Shiller PE Ratio was 17.38. The lowest was 8.38. And the median was 12.20.

BUE:GSK's Shiller PE Ratio is ranked better than
87.21% of 524 companies
in the Drug Manufacturers industry
Industry Median: 27.55 vs BUE:GSK: 10.68

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

GSK's adjusted earnings per share data for the three months ended in Mar. 2025 was ARS270.641. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ARS1,131.50 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


GSK Shiller PE Ratio Historical Data

The historical data trend for GSK's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GSK Shiller PE Ratio Chart

GSK Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.56 13.72 9.50 9.57 8.77

GSK Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.16 9.85 9.83 8.77 11.23

Competitive Comparison of GSK's Shiller PE Ratio

For the Drug Manufacturers - General subindustry, GSK's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GSK's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GSK's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where GSK's Shiller PE Ratio falls into.


;
;

GSK Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

GSK's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=12075.00/1131.50
=10.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GSK's E10 for the quarter that ended in Mar. 2025 is calculated as:

For example, GSK's adjusted earnings per share data for the three months ended in Mar. 2025 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=270.641/136.1000*136.1000
=270.641

Current CPI (Mar. 2025) = 136.1000.

GSK Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201506 0.274 100.100 0.373
201509 0.991 100.200 1.346
201512 -0.884 100.400 -1.198
201603 0.754 100.400 1.022
201606 -1.117 101.000 -1.505
201609 2.021 101.500 2.710
201612 0.643 102.200 0.856
201703 2.534 102.700 3.358
201706 -0.488 103.500 -0.642
201709 3.592 104.300 4.687
201712 -1.792 105.000 -2.323
201803 1.952 105.100 2.528
201806 1.845 105.900 2.371
201809 8.568 106.600 10.939
201812 7.278 107.100 9.249
201903 5.376 107.000 6.838
201906 6.831 107.900 8.616
201909 13.410 108.400 16.837
201912 12.681 108.500 15.907
202003 14.980 108.600 18.773
202006 24.098 108.800 30.145
202009 14.846 109.200 18.503
202012 9.161 109.400 11.397
202103 16.632 109.700 20.635
202106 22.919 111.400 28.001
202109 19.341 112.400 23.419
202112 12.338 114.700 14.640
202203 31.405 116.500 36.689
202206 12.211 120.500 13.792
202209 208.268 122.300 231.768
202212 37.267 125.300 40.479
202303 43.753 126.800 46.962
202306 60.152 129.400 63.267
202309 77.093 130.100 80.648
202312 19.421 130.500 20.254
202403 135.956 131.600 140.605
202406 162.352 133.000 166.136
202409 -8.801 133.500 -8.972
202412 63.843 135.100 64.316
202503 270.641 136.100 270.641

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


GSK  (BUE:GSK) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


GSK Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of GSK's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


GSK Business Description

Address
79 New Oxford Street, London, GBR, WC1A 1DG
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.